Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma

Purpose: The benefits of additional use of nimotuzumab (NTZ) in the treatment of locoregionally advanced nasopharyngeal carcinoma (LA-NPC) is largely unclear. We aim to compare LA-NPC treatment outcomes in patients that received CCRT with nimotuzumab (NTZ) to patients that received CCRT only. Materi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Ji-Jin, Zhang, Lu-Lu, Gao, Tian-Sheng, Peng, Ying-Lin, Lawrence, Wayne R., Zhang, Wang-Jian, Zhang, Fan, Zhou, Guan-Qun, Wang, Si-Yang, Sun, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301798/
https://www.ncbi.nlm.nih.gov/pubmed/30081714
http://dx.doi.org/10.1080/15384047.2018.1491501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301798/
https://www.ncbi.nlm.nih.gov/pubmed/30081714
http://dx.doi.org/10.1080/15384047.2018.1491501

Ejemplares similares